Hypolipidemic Agents
This graph shows the total number of publications written about "Hypolipidemic Agents" by people in the URMC Research Network by year, and whether "Hypolipidemic Agents" was a major or minor topic of these publication.
Below are the most recent publications written about "Hypolipidemic Agents" by people in Profiles.
-
Kopin L, Lowenstein C. In the clinic. Dyslipidemia. Ann Intern Med. 2010 Aug 3; 153(3):ITC21.
-
Brodov Y, Behar S, Goldenberg I, Boyko V, Chouraqui P. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study). Am J Cardiol. 2009 Jul 15; 104(2):194-8.
-
Phipps RP, Blumberg N. Statin islands and PPAR ligands in platelets. Arterioscler Thromb Vasc Biol. 2009 May; 29(5):620-1.
-
Goldenberg I, Boyko V, Tennenbaum A, Tanne D, Behar S, Guetta V. Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial. Arch Intern Med. 2009 Mar 9; 169(5):508-14.
-
Hou R, Goldberg AC. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Endocrinol Metab Clin North Am. 2009 Mar; 38(1):79-97.
-
Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Am J Cardiol. 2009 Jan 1; 103(1):41-5.
-
Tenenbaum A, Boyko V, Fisman EZ, Goldenberg I, Adler Y, Feinberg MS, Motro M, Tanne D, Shemesh J, Schwammenthal E, Behar S. Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Cardiovasc Diabetol. 2008; 7:18.
-
Ma Y, Li W, Olendzki BC, Pagoto SL, Merriam PA, Chiriboga DE, Griffith JA, Bodenlos J, Wang Y, Ockene IS. Dietary quality 1 year after diagnosis of coronary heart disease. J Am Diet Assoc. 2008 Feb; 108(2):240-6; discussion 246-7.
-
Goldenberg I, Benderly M, Goldbourt U. Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial. J Am Coll Cardiol. 2008 Jan 29; 51(4):459-65.
-
Goldenberg I, Benderly M, Goldbourt U. Update on the use of fibrates: focus on bezafibrate. Vasc Health Risk Manag. 2008; 4(1):131-41.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
